AdaptHealth (AHCO) Scheduled to Post Earnings on Tuesday

AdaptHealth (NASDAQ:AHCO - Get Free Report) will be posting its quarterly earnings results before the market opens on Tuesday, November 5th. Analysts expect AdaptHealth to post earnings of $0.17 per share for the quarter. AdaptHealth has set its FY 2024 guidance at EPS.Persons that wish to listen to the company's earnings conference call can do so using this link.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The company had revenue of $805.98 million during the quarter, compared to analyst estimates of $802.62 million. AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The business's revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.16 earnings per share. On average, analysts expect AdaptHealth to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

AdaptHealth Stock Performance

Shares of AdaptHealth stock traded up $0.03 on Tuesday, reaching $10.85. 329,271 shares of the company were exchanged, compared to its average volume of 1,054,991. AdaptHealth has a 1-year low of $6.37 and a 1-year high of $11.90. The firm has a market cap of $1.46 billion, a price-to-earnings ratio of -2.05, a P/E/G ratio of 1.60 and a beta of 1.10. The company has a debt-to-equity ratio of 1.38, a quick ratio of 0.94 and a current ratio of 1.15. The company's 50-day moving average is $10.77 and its two-hundred day moving average is $10.41.

Analyst Ratings Changes

Separately, Royal Bank of Canada restated an "outperform" rating and set a $13.00 price target on shares of AdaptHealth in a research report on Monday, August 12th. One analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, AdaptHealth has an average rating of "Hold" and a consensus target price of $10.70.

Insiders Place Their Bets

In other AdaptHealth news, Director David Solomon Williams III sold 4,000 shares of the business's stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $11.26, for a total transaction of $45,040.00. Following the sale, the director now directly owns 36,899 shares in the company, valued at approximately $415,482.74. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director David Solomon Williams III sold 4,000 shares of the business's stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $11.26, for a total value of $45,040.00. Following the sale, the director now owns 36,899 shares of the company's stock, valued at approximately $415,482.74. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, COO Shaw Rietkerk sold 25,000 shares of AdaptHealth stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $11.24, for a total value of $281,000.00. Following the transaction, the chief operating officer now directly owns 212,611 shares in the company, valued at approximately $2,389,747.64. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.43% of the stock is currently owned by insiders.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.